The Trust Layer for Market Analysts

The analysis projects a bullish trajectory for Injective Protocol (INJUSDT) into 2026, targeting an approximate price of $78.412 from its current standing at $5.843. Despite a 77% downturn in 2025, INJ has demonstrated a 27% increase at the commencement of 2026. The central tenet of this bullish outlook is a proprietary valuation model that identifies assets oscillating between undervaluation and overvaluation phases. INJ is currently positioned within a significantly undervalued zone, historically correlating with impending upward price surges. The expectation is for a consolidation period through January 2026, preceding a substantial breakout and subsequent rally to potentially new all-time highs. This bullish scenario would be invalidated if INJUSDT's price were to descend below approximately $3.800, a critical support threshold within the identified undervaluation range. This asset-specific technical analysis is corroborated by a broader crypto market outlook. A predicted decline in USDT dominance is anticipated to redirect capital into altcoins, while a projected peak in Bitcoin dominance traditionally paves the way for altcoin rallies. Both the total crypto market cap and the altcoin market cap (excluding Bitcoin) are situated at robust support levels, suggesting ample liquidity to fuel a sustained bullish momentum across the altcoin sector.